A bill to withdraw approval for the drug Zohydro ER and prohibit the Food and Drug Administration from approving such drug unless it is reformulated to prevent abuse.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senator for West Virginia. Democrat.
Last Updated: Mar 13, 2014
Length: 4 pages
113th Congress (2013–2015)
This bill was introduced on March 13, 2014, in a previous session of Congress, but was not enacted.
Mar 13, 2014
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
S. 2134 (113th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number S. 2134. This is the one from the 113th Congress.
This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2020). S. 2134 — 113th Congress: Act to Ban Zohydro. Retrieved from https://www.govtrack.us/congress/bills/113/s2134
“S. 2134 — 113th Congress: Act to Ban Zohydro.” www.GovTrack.us. 2014. May 31, 2020 <https://www.govtrack.us/congress/bills/113/s2134>
Act to Ban Zohydro, S. 2134, 113th Cong. (2014).
|title=S. 2134 (113th)
|accessdate=May 31, 2020
|author=113th Congress (2014)
|date=March 13, 2014
|quote=Act to Ban Zohydro
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.